Kolhapur, India

Patil Dattatray Bapuso

This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Patil Dattatray Bapuso. Retrieved from https://idiyas.com/inventor/patil-dattatray-bapuso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Patil Dattatray Bapuso: Innovator in Pharmaceutical Chemistry

Introduction

Patil Dattatray Bapuso is a notable inventor based in Kolhapur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work has implications for the production of important medications.

Latest Patents

One of his key patents is titled "Process for the preparation of orlistat." This invention provides a method for preparing orlistat from amino orlistat using Pivaloyl Formic Anhydride (PFA) as an alkanoylating agent. This innovative process enhances the efficiency of orlistat production, which is crucial for weight management therapies.

Career Highlights

Patil Dattatray Bapuso is associated with Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His role at the company has allowed him to apply his expertise in drug formulation and development. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Patil has collaborated with several professionals, including Ashok Prasad and Mohan Prasad. These collaborations have fostered a productive environment for innovation and have led to the successful development of various pharmaceutical processes.

Conclusion

Patil Dattatray Bapuso's work exemplifies the impact of innovation in the pharmaceutical industry. His patent for the preparation of orlistat showcases his commitment to advancing drug development processes. His contributions continue to influence the field and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…